Kinnevik (KINV) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Jul, 2026Executive summary
Net asset value (NAV) increased 6% quarter-over-quarter to SEK 29.6bn, driven by portfolio company growth, multiple expansion among listed peers, and positive currency effects.
Strategic focus on transitioning to a smaller, more disciplined, achievement-oriented organization, reducing team size and management cash costs to SEK 200m by 2027.
Management transitions underway: new CEO Helena Saxon and interim CFO appointed, with a new Director of Communications & Investor Relations joining.
Comprehensive internal portfolio review completed, shifting toward a more concentrated, cash-generative, and balanced risk profile.
Agreements signed to divest Oda and YouScan, with expected Q3 cash proceeds of SEK 133m.
Financial highlights
NAV per share at SEK 107; net cash position of SEK 7.4bn at quarter-end, expected to rise to SEK 7.6bn after divestments.
Q2 2026 net profit of SEK 1,717m, up from SEK 626m in Q2 2025; H1 2026 net loss of SEK 6,252m.
Net investments of SEK 57m in Q2, the lowest since Q4 2019.
Larger portfolio companies achieved 28% weighted average sales growth year-to-date, with EBITDA margin improving by 4 percentage points to -6%.
Health & Bio segment up 16%, led by Spring Health's 29% write-up and Alma acquisition; Software up 7%, Perk as largest contributor; Emerging companies up 12% due to Wordsmith's 14x revenue growth.
Outlook and guidance
Continued focus on cost discipline, capital preservation, and selective follow-on investments, with a SEK 1.5bn cap for follow-ons.
New CEO to shape updated investment strategy, pivoting toward later-stage, cash-generative enterprises and a more balanced risk profile.
Larger portfolio companies projected to grow sales 25-35% year-over-year in the next 12 months, with EBITDA margins improving toward break-even.
No immediate plans for IPOs of major holdings, but favorable public market conditions noted.
80% of the private portfolio is profitable or financed to break-even under current plans.
Latest events from Kinnevik
- NAV fell 8% to SEK 35.9bn as market headwinds offset robust core company growth.KINV
Q4 20258 Jul 2026 - New CEO appointed, portfolio companies excel, and SaaS valuations shift across subsectors.KINV
Pre-silent presentation22 Jun 2026 - NAV dropped 22% to SEK 27.9bn, net loss SEK 7,969m, with cost cuts and portfolio refocus underway.KINV
Q1 202616 Apr 2026 - AI-driven derating and macro uncertainty caused sharp valuation drops across key portfolio sectors.KINV
Pre-silent presentation7 Apr 2026 - NAV fell 4.7–5% as core growth companies outperformed and capital deployment set to rise.KINV
Q2 20243 Feb 2026 - Strong portfolio growth offset by 15–20% valuation headwinds from market and currency shifts.KINV
Pre-silent presentation26 Jan 2026 - NAV fell 5% to SEK 37.4bn as VillageMD was written down, but core assets grew over 60%.KINV
Q3 202419 Jan 2026 - Focused on high-growth private assets in health, software, and climate tech, targeting 15–25%+ returns.KINV
CMD 202419 Jan 2026 - NAV up 5% to SEK 39.2bn, core companies grew 55%, strong SEK 10.9bn net cash for growth.KINV
Q4 20249 Jan 2026